Adelphi Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,584,930
| Closed | -$138M | – | 3 |
|
|
2020
Q4 | $138M | Sell |
7,584,930
-689,297
| -8% | -$12.5M | 26.79% | 2 |
|
|
2020
Q3 | $148M | Sell |
8,274,227
-882,088
| -10% | -$15.7M | 28.67% | 2 |
|
|
2020
Q2 | $164M | Sell |
9,156,315
-126,228
| -1% | -$2.26M | 36.01% | 2 |
|
|
2020
Q1 | $141M | Buy |
9,282,543
+323,759
| +4% | +$4.91M | 33.82% | 2 |
|
|
2019
Q4 | $177M | Sell |
8,958,784
-32,506
| -0.4% | -$641K | 33.75% | 2 |
|
|
2019
Q3 | $155M | Buy |
8,991,290
+1,060,174
| +13% | +$18.2M | 33.43% | 2 |
|
|
2019
Q2 | $140M | Sell |
7,931,116
-1,339,419
| -14% | -$23.7M | 32.92% | 2 |
|
|
2019
Q1 | $189M | Buy |
+9,270,535
| New | +$189M | 39.13% | 2 |
|